Results 11 to 20 of about 50,642 (200)

Rare manifestations of cutaneous diphtheria: a case report [PDF]

open access: yesJournal of Medical Case Reports
Background This case report presents an exceptionally rare and atypical presentation of diphtheria in a 17-year-old female of Hausa ethnicity residing in an area with an elevated incidence within Kano State, Nigeria.
Salma Ali Suwaid   +5 more
doaj   +2 more sources

Challenges of Diphtheria Toxin Detection [PDF]

open access: yesToxins
Diphtheria toxin (DT) is the main virulence factor of Corynebacterium diphtheriae, C. ulcerans and C. pseudotuberculosis. Moreover, new Corynebacterium species with the potential to produce diphtheria toxin have also been described.
Marta Prygiel   +6 more
doaj   +2 more sources

Passive Immunisation in the Treatment of Infectious Diseases Related to Highly Potent Bacterial Toxins [PDF]

open access: yesBiomedicines
The discovery of microbial toxins as the primary factors responsible for disease manifestations and the discovery that these toxins could be neutralised by antitoxins are linked to the birth of immunology. In the late 19th century, the serum or plasma of
Marta Prygiel   +3 more
doaj   +2 more sources

Antimicrobial Susceptibility of Toxin-Producing Corynebacterium diphtheriae and C. ulcerans in Belgium [PDF]

open access: yesAntibiotics
Background/Objectives: Despite a significant reduction in diphtheria incidence and mortality due to vaccination, antitoxin therapy and antibiotic treatments, a concerning resurgence is occurring in Europe.
Zan Janssen   +6 more
doaj   +2 more sources

Identification of a human monoclonal antibody to replace equine diphtheria antitoxin for treatment of diphtheria intoxication. [PDF]

open access: yesInfect Immun, 2013
Sevigny LM   +9 more
europepmc   +2 more sources

An enhanced intracellular delivery platform based on a distant diphtheria toxin homolog that evades pre-existing antitoxin antibodies [PDF]

open access: yesEMBO Molecular Medicine
Targeted intracellular delivery of therapeutic proteins remains a significant unmet challenge in biotechnology. A promising approach is to leverage the intrinsic capabilities of bacterial toxins like diphtheria toxin (DT) to deliver a potent cytotoxic ...
Shivneet K Gill   +5 more
doaj   +2 more sources

Diphtheria in Children- Clinical Profile of Cases during an Outbreak in Kerala, India [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2022
Introduction: Diphtheria is an acute potentially fatal infectious disease caused by the toxigenic strains of Corynebacterium diphtheriae. Acute respiratory obstruction, toxic myocarditis and neurologic weakness are the most important complications of ...
Thekkile Gangadharan Sindhu   +4 more
doaj   +1 more source

Adverse events following the administration of diphtheria antitoxin (Equine Source): An observational study in an Indian tertiary care centre

open access: yesPANACEA JOURNAL OF MEDICAL SCIENCES, 2022
To assess the clinical safety of diphtheria antitoxin in patients with probable and confirmed diphtheria infection. This was a single-center, observational study which included patients with probable and/or confirmed diphtheria infection.
T. Reddy, M. A. Kumar, K. Shankar
semanticscholar   +1 more source

Diphtheria: A case series from West Maharashtra, India

open access: yesJournal of Medical Sciences and Health, 2022
Diphtheria is an acute infectious toxin mediated disease caused by Corynebacterium diphtheriae. Effective vaccination has decreased the incidence of disease globally. However, despite of a full-fledged Universal Immunization Programme, the cases
Snehal Patil   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy